Form 4 for CRL Charles River Laboratories
Accepted 2024-01-31 00:00:00 ET · period of report 2024-01-29 · accession 0001127602-24-002794 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-31 | 2024-01-29 | CRL | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +2,997 | 12.1K | +33% | $0 | |
| 2024-01-31 | 2024-01-29 | CRL | Barbo William D | CCO, Corp. Executive VP | F - Tax | $220.28 | -770 | 11.3K | -6% | -$169.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-29 | A | A | 2,997 | $0.00 | 12,100 | D | — | — | (F1) Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. |
| 2 | Common | Common Stock | 2024-01-29 | F | D | 770 | $220.28 | 11,330 | D | — | — |